1 Colon MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.

Slides:



Advertisements
Similar presentations
Coding Complex Morphologies in ICD-O-3
Advertisements

Tumors of Intestines.
Instructions and Reporting Requirements Module 2 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Polyps – Where do they come from and what do you do with them?!
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
The Adenoma/Carcinoma Sequence in the Colon
Management of a rare type of Ca appendix Dr. Lam Tang Yu Tuen Mun Hospital Joint Hospital Surgical Grand Round.
Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Introduction to Neoplasia
Hematopoietic and Lymphoid Neoplasm Project. Primary Site and Histology Rules Peggy Adamo, RHIT, CTR NCI SEER October 2009.
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
Procedures used by CHTN
Joint Hospital Surgical Grand Round 19 June 2004.
Colorectal cancer Khayal AlKhayal MD,FRCSC
MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007
NEOPLASIA (Malignant Tumors)
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
1 LUNG. 2 Equivalent Terms, Def, Charts, Tables, Illustrations.
Small Bowel Tumors Keith D. Lillemoe M.D. Dept. of Surgery
Colorectal carcinoma Dr.Mohammadzadeh.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
1 Other Sites MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Osteosarcoma DR: Gehan mohamed 1. 10/5/20152 Osteosarcoma.
Head and Neck MP/H Task Force Multiple Primary Rules
1 Head and Neck. 2 Equivalent Terms, Definitions, Charts, Tables and Illustrations Primary site –Do not code biopsy site.
What’s the Diff? Sue C. Vest, CTR Missouri Cancer Registry This project was supported in part by a cooperative agreement between the Centers for Disease.
1 Cutaneous Melanoma MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Gastric carcinoma.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
PUBLIC HEALTH DIVISION Oregon State Cancer Registry Abstracting Hematologic Malignancies Stepping Up Your Game LeeLa Coleman, CTR Cancer Data Consultant.
KCR 2014 Spring Training CHANGES IN CODING GRADE.
The “Hand” of Appendix Cancer Presented to American Association of Primary Care Endoscopy Brian W. Meeker, D.O. Vinton, Ia. 53 y/o male presents for “screening”
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
Vicki LaRue, CTR KCR Abstractor’s Training February 12,
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
BY FRANCES ROSS, CTR PRESENTED AT THE NAACCR ANNUAL CONFERENCE JUNE, 2008 Record Consolidation Test with the 2007 Multiple Primary/Histology Rules.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
NEOPLASIA Dr. Manal Maher Hussein.
위암병리보고서의 기재사항 서울대학교 김 우 호.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
1 Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
1. Multiple Primary and Histology Rules 101 Format of MP/H Materials.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Adenoma of the ampulla of vater
GI Path Exam 2. Most common neoplastic polyp? Most common location and size of colonic hyperplastic polyps?
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
2016 Edits.
Multiple Primary and Histology Coding Rules Colon Cancer
Large Bowel.
2018 Solid Tumor Rules: What’s New- Working through the rules
Chapter 5 Tumor , neoplasm Department of pathology.
Irritable Bowel Syndrome
Dr.Amit Gupta Associate Professor Dept. of Surgery
By Dr. Abdelaty Shawky Assistant professor of pathology
Stomach cancer Also called gastric cancer is cancer arising from stomach tissue.it is uncontrolled cell growth of stomach layers lead to dysfunction of.
Dr Amit Gupta Associate Professor Dept of Surgery
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
What’s New for 8th Edition
From NICE CG 104, 2010 Table 1 Terms used in this guideline
Colonic polyps and tumors
Presentation transcript:

1 Colon MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

2 Equivalent Terms, Definitions, and Illustrations 98% adenocarcinoma –10-15% produce enough mucin to be mucinous

3 Equivalent Terms, Definitions, and Illustrations Mixed histologies –Mucinous/colloid –Signet ring –Others are rare

4 Equivalent Terms, Definitions, and Illustrations Adenocarcinoma with mixed subtypes (8255): Rarely used for colon primaries (see introduction). Adenocarcinoma, intestinal type (8144) is a form of stomach cancer. Do not use this code when the tumor arises in the colon.

5 Multiple Primary Rules MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

6 Unknown if Single or Multiple Tumors MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

7 RuleSite/Histology/Timing/BehaviorNotes/ Examples Primary UNKNOWN IF SINGLE OR MULTIPLE TUMORS Tumor(s) not described as metastasis M1Use this rule only after all information sources have been exhausted. Single

8 Single Tumor MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

9 RuleSiteNotes/ExamplesPrimary SINGLE TUMOR 1. Tumor not described as metastasis 2. Includes combinations of in situ and invasive M2SingleTumor may overlap onto or extend into adjacent/contiguous site or subsite Single

10 Multiple Tumors MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

11 RuleHistologyNotes/ExamplesPrimary MULTIPLE TUMORS Multiple tumors may be a single primary or multiple primaries 1. Tumors not described as metastases 2. Includes combinations of in situ and invasive M3Adenocarcinoma in adenomatous polyposis (familial polyposis) with one or more malignant polyps Tumors may be present in multiple segments of the colon or in a single segment of the colon. Single

12 RuleSitePrimary M4Sites with topography codes that are different at the second (Cxxx), third (Cxxx) or fourth (C18x) character Multiple

13 RuleTimingPrimary M5Diagnosed more than one (1) year apartMultiple

14 RuleTimingBehaviorNotes/ExamplesPrimary M6More than 60 days after diagnosis An invasive tumor following an in situ tumor 1: The purpose of this rule is to ensure that the case is counted as an incident (invasive) case when incidence data are analyzed. 2: Abstract as multiple primaries even if the medical record/physician states it is recurrence or progression of disease. Multiple

15 RuleHistologyPrimary M7A frank in situ or malignant adenocarcinoma and an in situ or malignant tumor in a polyp Single

16 RuleHistologyPrimary M8  Cancer/malignant neoplasm, NOS (8000) and a specific histology; OR  Carcinoma, NOS (8010) and a specific carcinoma; OR  Adenocarcinoma, NOS (8140) and a specific adenocarcinoma; OR  Sarcoma, NOS (8800) and a specific sarcoma Single

17 RuleHistologyNotes/ExamplesPrimary M9Multiple in situ and/or malignant polyps Includes all combinations of adenomatous, tubular, villous, and tubulovillous adenomas or polyps. Single

18 RuleHistologyPrimary M10Histology codes are different at the first (xxxx), second (xxxx), or third (xxxx) number Multiple

19 RuleHistologyNotes/ExamplesPrimary M11Does not meet any of the above criteria 1: When an invasive lesion follows an in situ within 60 days, abstract as a single primary. 2: All cases covered by Rule M11 are in the same segment of the colon Single

20 Histology Rules MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

21 Single Tumor MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

22 RulePathology/ Cytology Notes/ExamplesCode SINGLE TUMOR H1 No pathology / cytology specimen or the pathology/ cytology report is not available 1: Priority for using documents to code the histology  Documentation in the medical record that refers to pathologic or cytologic findings  Physician’s reference to type of cancer (histology) in the medical record  CT, PET or MRI scans 2: Code the specific histology when documented. 3: Code the histology to 8000 (cancer/malignant neoplasm, NOS) or 8010 (carcinoma, NOS) as stated by the physician when nothing more specific is documented The histology documented by the physician

23 RulePathology/ Cytology Notes/ExamplesCode H2None from primary site Code the behavior /3The histology from metastatic site

24 RuleHistologyNotes/ExamplesCode H3Intestinal type adenocarcinoma or adenocarcinoma, intestinal type 1: Intestinal type adenocarcinoma usually occurs in the stomach. 2: When a diagnosis of intestinal adenocarcinoma is further described by a specific term such as type, continue to the next rule (Adeno- carcinoma, NOS)

25 RuleHistologyNotes/ Examples Code H4Final diagnosis:  Adenocarcinoma in a polyp  Adenocarcinoma and a residual polyp or polyp architecture is recorded in other parts of the pathology report.  Adenocarcinoma and there is reference to a residual or pre- existing polyp within the medical record or  Mucinous/colloid or signet ring cell adenocarcinoma in a polyp or There is documentation that the patient had a polypectomy It is important to know that the adenocar- cinoma originated in a polyp (Adeno- carcinoma arising in polyp), or 8261 (Adeno- carcinoma in a villous adenoma), or 8263 (Adeno- carcinoma in a tubulovillous adenoma)

26 RuleHistologyCode H5Final diagnosis is:  Mucinous/colloid (8480) or signet ring cell carcinoma (8490) or  Adenocarcinoma, NOS and microscopic description documents 50% or more of the tumor is mucinous/colloid or  Adenocarcinoma, NOS and microscopic description documents 50% or more of the tumor is signet ring cell carcinoma 8480 (Mucinous/colloid adenocarcinoma) or 8490 (Signet ring cell carcinoma)

27 RuleHistologyCode H6Final diagnosis is adenocarcinoma and:  Microscopic description states less than 50% of the tumor is mucinous/colloid, or  Microscopic description states less than 50% of the tumor is signet ring cell carcinoma, or  Percentage of Mucinous/colloid or signet ring cell carcinoma is unknown 8140 (Adenocarcinoma, NOS)

28 RuleHistologyCode H7Combination of mucinous/colloid and signet ring cell carcinoma 8255 (Adenocarcinoma with mixed subtypes)

29 RuleHistologyCode H8Neuroendocrine carcinoma (8246) and carcinoid tumor (8240) 8240 (Carcinoid tumor, NOS)

30 RuleHistologyCode H9Adenocarcinoma and carcinoid tumor 8244 (Composite carcinoid)

31 RuleHistologyCode H10Exactly “adenocarcinoid”8245 (Adenocarcinoid)

32 RuleHistologyCode H11One typeThe histology

33 RuleBehaviorCode H12Invasive and in situThe invasive histologic type

34 RuleHistologyNotes/ExamplesCode H13  Cancer/malignant neoplasm, NOS (8000) and a more specific histology or  Carcinoma, NOS (8010) and a more specific carcinoma or  Adenocarcinoma, NOS (8140) and a more specific adenocarcinoma or  Sarcoma, NOS (8800) and a more specific sarcoma (invasive only) 1. The specific histology for in situ tumors may be identified as pattern, architecture, type, subtype, predominantly, with features of, major, or with ____differentiation. 2. The specific histology for invasive tumors may be identified as type, subtype, predominantly, with features of, major, or with ____differentiation. The most specific histologic term

35 RuleHistologyCode H14None of the above conditions are met The histology with the numerically higher ICD-O-3 code

36 Multiple Tumors Abstracted as a Single Primary MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007

37 RulePathology/ Cytology Notes/ExamplesCode MULTIPLE TUMORS ABSTRACTED AS A SINGLE PRIMARY These rules only apply to multiple tumors that are reported as a single primary H15No pathology/cyt ology specimen or the pathology/cyt ology report is not available 1: Priority for using documents to code the histology  Documentation in the medical record that refers to pathologic or cytologic findings  Physician’s reference to type of cancer (histology) in the medical record  CT, PET or MRI scans 2: Code the specific histology when documented 3: Code the histology to 8000 (cancer/malignant neoplasm, NOS) or 8010 (carcinoma, NOS) as stated by the physician when nothing more specific is documented The histology document-ed by the physician

38 RulePathology/ Cytology Notes/ Examples Code H16None from primary site Code the behavior /3 The histology from a metastatic site

39 RuleHistologyCode H17  Clinical history says familial polyposis and final diagnosis on pathology report from resection is adenocarcinoma in adenomatous polyps, or  > 100 polyps in resected specimen  Number of polyps is not given but the diagnosis is familial polyposis 8220 (Adenocarcinoma in adenomatous polyposis coli)

40 RuleHistologyCode H18Multiple in situ or malignant polyps are present, at least one of which is tubulovillous 8263 (Adenocarcinoma in a tubulovillous adenoma)

41 RuleHistologyCode H19  <= 100 polyps in resected specimen, or  Multiple polyps and the number of polyps is not given and familial polyposis is not mentioned 8221 (adenocarcinoma in multiple adenomatous polyps)

42 RuleHistologyNotes/ExamplesCode H20  Frank adenocarcinoma and a carcinoma in a polyp, or  In situ and invasive tumors  Multiple invasive tumors 1: See the Colon Equivalent Terms, Definitions and Illustrations for the definition of most invasive.  One tumor is in situ and one is invasive, code the histology from the invasive tumor.  Both/all histologies are invasive, code the histology of the most invasive tumor. 2. If tumors are equally invasive, go to the next rule The histology of the most invasive tumor

43 RuleHistologyNotes/ Examples Code H21Final diagnosis:  Adenocarcinoma and the microscopic description or surgical gross describes polyps or  Adenocarcinoma and there is reference to residual or pre- existing polyps or  Mucinous/colloid or signet ring cell adenocarcinoma in polyps or There is documentation that the patient had a polypectomy It is important to know that the adeno- carcinoma originated in a polyp (Adenocarcinoma arising in polyp), or 8261 (Adenocarcinoma in a villous adenoma), or 8263 (Adenocarcinoma in a tubulovillous adenocarcinoma)

44 RuleHistologyCode H22One typeThe histology

45 RuleHistologyNotes/ExamplesCode H23  Cancer/malignant neoplasm, NOS (8000) and a specific histology or  Carcinoma, NOS (8010) and a specific carcinoma or  Adenocarcinoma, NOS (8140) and a specific adenocarcinoma or  Sarcoma, NOS (8800) and a specific sarcoma (invasive only) 1: The specific histology for in situ tumors may be identified as pattern, architecture, type, subtype, predominantly, with features of, major, or with ____differentiation 2: The specific histology for invasive tumors may be identified as type, subtype, predominantly, with features of, major, or with ____differentiation. The more specific histologic term

46 RuleHistologyCode H24None of the above conditions are metThe histology with the numerically higher ICD-O-3 code

47 MP/H Task Force